Novel Treatments for Neuromuscular Disorders

Flex Pharma, Inc. is a biotechnology company that is developing innovative and proprietary treatments for cramps and spasms associated with the severe neurological diseases of ALS, MS and peripheral neuropathies such as Charcot-Marie-Tooth (CMT). 


February 14, 2017 Flex Pharma to Present at the 2017 BIO CEO & Investor Conference
Read More

January 24, 2017 Flex Pharma Focuses on Phase 2 Clinical Programs in Severe Neurological Diseases
Read More